Abortion Pill Startup Choice Raises $1M in Venture Capital

For many women, abortion pills are an easy and safe way to terminate a pregnancy within the first 10 weeks. These pills have become more and more common, even if some states decide to restrict access to them. Choix, which means “choice” in French, connects clients with a medical provider within 24 hours of completing a questionnaire. Then, for $289, he sends patients seeking abortion mifepristone pills. Patients must be 16 or older and reside in California, Colorado or Illinois. Adam said Choice has worked with around 3,500 patients since its launch in October 2020 and has grown rapidly during the pandemic as telehealth has become more popular.

Adam, a nurse practitioner, said the new funding will help the company grow its team, currently less than a dozen employees, and expand into other states where it is able to operate legally. . Choice also offers other reproductive and sexual health care services, including the morning after pill and treatment for urinary tract infections and genital herpes.

In the coming months, Choice plans to raise an additional $500,000 or $1 million, Adam said, adding that the company has garnered more interest from investors since a leaked draft opinion signaled that the Supreme Court could end the constitutional right to abortion.

The company joins a range of services and non-profit organizations trying to provide increased access to abortion drugs by mail. Aid Access, started by a Dutch doctor, sends pills to a patient’s home from abroad. Meanwhile, Hey Jane, another venture capital-backed telehealth company that sends abortion medication, raised $3.6 million in seed funding.

Adam said Choice debated whether it should operate as a nonprofit, but decided to seek venture capital funding so it could ramp up operations. “There’s already a lot of limited funding that independent clinics and a lot of nonprofits are looking for,” she said. “We’ve seen an increase in the number of interested partners since the leak, so we’re really excited about the potential for other investors.”

Subscribe to Crain’s for $3.25 per week